Scholars Central

Conference abstractPublished 2016

Artemis inhibitor: A new approach for radiotherapy

Authors: Sadia Nazir, Nasir Jalal, Namrah Anwar, Saba Haq

National University of Sciences and Technology, Pakistan Tianjin University, China

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The higher relative biological effectiveness (RBE) or radiation weighting factor (WR) of any prescribed radiotherapy determines the effectiveness of radiation dose to kill the target cells in a biological system. Currently our knowledge limits the effectiveness to the radiation source and type of radiation that deposits energy into the target tissue. However the RBE and WR can be enhanced by two folds if the target tumor mass can be radio-sensitized with small molecule inhibitors that inhibit the DNA repair process, before tumor cells are bombarded with the radiation dose. We propose the development of radio-sensitizers from inhibitors of Artemis and DNA-PKcs as they increase the cancer cell lethality when coupled with ionizing radiation (IR). Inhibitor of non-homologous endjoining repair (NHEJ) pathway enzyme DNA-PKcs (NU7026) at 10 μM concentration lowers cell viability by up to 50% at 4Gy of the radiation dose (CO60 gamma source). DNA-PKcs inhibition resulted in defects in repair pathway while the novel Artemis inhibitor (purchased from University of California) did not show these effects. Inhibition of artemis followed by IR caused increased cell killing of four primary ductal carcinoma cell lines at low dose of radiation as compared to DNA- PKcs. DNA repair changes were not significant for artemis inhibition. We used 2-hydroxy-5-methoxybenzaldehyde 4-anilino-6-(3, 5-dimethyl-H-pyrazolyl)-, 3, 5-triazin- 2-ylhydrazone for the inhibition of Artemis and results were compared to literature where siRNA was used for Artemis inhibition. To achieve improved therapeutic ratio such radio-sensitizers are a need of the hour and should be developed as chemotherapeutic drugs.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pharmaceutics & Drug Delivery Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmaceutics & Drug Delivery Research
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Sadia Nazir”
  • BylineArticles whose byline prints “Nasir Jalal”
  • BylineArticles whose byline prints “Namrah Anwar”
  • BylineArticles whose byline prints “Saba Haq”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels